Patient-blood management for COVID19 convalescent plasma therapy: relevance of affinity and donor–recipient differences in concentration of neutralizing antibodies

BACKGROUND: Coronavirus disease 2019 (COVID-19) convalescent plasma (CCP) is being extensively investigated as a treatment, with mixed results to date. Overall, there has been a generalized lack of appropriateness in prescriptions, which, in the field of transfusion medicine, is termed patient-blood...

Descripción completa

Detalles Bibliográficos
Autores principales: Focosi, Daniele, Maggi, Fabrizio, Franchini, Massimo, Aguzzi, Adriano, Lanza, Maria, Mazzoni, Alessandro, Menichetti, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2021
Materias:
Narrative Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052606/
https://www.ncbi.nlm.nih.gov/pubmed/33878505
http://dx.doi.org/10.1016/j.cmi.2021.04.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052606/
https://www.ncbi.nlm.nih.gov/pubmed/33878505
http://dx.doi.org/10.1016/j.cmi.2021.04.003

Ejemplares similares